Summary
The continuous intraventricular administration of small daily doses of morphine by means of an implantable pump is an effective method of obtaining considerable pain reduction for patients suffering from otherwise untractable carcinoma pain. We consider this method of treatment to be an excellent alternative to the epidural and intrathecal application. Particularly in cases with obstruction of the spinal canal or in cases suffering from untractable pain in the face, neck or upper thoracic area. During the period of treatment, none of the patients involved in the study developed tolerance to morphine or specific opiate side effects. The programmable pump allows precise dosage which is adjusted to the requirements of the individual patient. The high cost of a pump is a justifyable investment in patients in good general condition with a life expectancy longer than 3 months. In most cases the patient may be cared for at home, making further hospitalization unnecessary.
Chapter PDF
References
Chrubasik J (1985) Spinal infusion of opiates and somatostatin. Fresenius Foundation, FRG
Chrubasik J, Volk B, Meynadier J, Berg G, Wuensch E (1986) Observations in dogs receiving chronic spinal somatostatin and calcitonin. Schmerz-Pain-Douleur 1: 10–12
Coombs DW, Saunders RL, Pageau MG (1982) Continuous intraspinal narcotic analgesia. Technical aspects of an implantable infusion pump. Reg Anesth 7: 110–113
Crawford ME etal (1983) Pain treatment on outpatient basis utilizing extradural opiates. A danish multicentre study comprising 105 patients. Pain 16: 41
Friedrich G, Chrubasik J, Scholler KL, Andreas P, Rupp HP, Weigel K, Roth H (1985) Peridurale Morphinapplikation: Zum Risiko der Atemdepression. Schmerz 6: 10
Greenberg SH, Taren J, Ensminger WD, Doan K (1982) Benefit from and tolerance to continuous intrathecal infusion of morphine for intractable cancer pain. Neurosurg 57: 360
Leavens ME, Hills CS Jr, Cech DH, Weyland JB, Westen JS (1982) Intrathecal and intraventricular morphine for pain in cancer patients; initial study. J Neurosurg 56: 241
Lobato RD, Madrid JC, Fatela LV (1983) Intraventricular morphine for control pain in terminal cancer patients. J Neurosurg 59: 627
Milne B, Cervenko F, Jhamandas K, Loomis Chr, Sutak M (1985) Analgesia and tolerance to intrathecal morphine and norepinephrine infusion via implanted miniosmotic pumps in the rat. Pain 22: 165–172
Snyder SH, Childers SR (1979) Opiate receptors and opioid peptides. Ann Rev Neurosci 2: 35
Wang JK, Nauss LA, Thomas JE (1979) Pain relief by intrathecally applied morphine in man. Anesthesiology 50: 149
Yaksh TL (1981) Special opiate analgesia: characteristics and principles of action. Pain 11: 293
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag
About this paper
Cite this paper
Weigel, K., Mundinger, F., Chrubasik, J. (1987). Continuous Intraventricular Morphine- or Peptide-Infusion for Intractable Cancer Pain. In: Gybels, J., Hitchcock, E.R., Meyerson, B., Ostertag, C., Rossi, G.F. (eds) Advances in Stereotactic and Functional Neurosurgery 7. Acta Neurochirurgica Supplementum, vol 39. Springer, Vienna. https://doi.org/10.1007/978-3-7091-8909-2_43
Download citation
DOI: https://doi.org/10.1007/978-3-7091-8909-2_43
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-8911-5
Online ISBN: 978-3-7091-8909-2
eBook Packages: Springer Book Archive